Cargando…

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

SynergyFinder (https://synergyfinder.fimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianevski, Aleksandr, Giri, Anil K, Aittokallio, Tero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252834/
https://www.ncbi.nlm.nih.gov/pubmed/35580060
http://dx.doi.org/10.1093/nar/gkac382
_version_ 1784740360399880192
author Ianevski, Aleksandr
Giri, Anil K
Aittokallio, Tero
author_facet Ianevski, Aleksandr
Giri, Anil K
Aittokallio, Tero
author_sort Ianevski, Aleksandr
collection PubMed
description SynergyFinder (https://synergyfinder.fimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the development of its functionality and graphical interface has been driven by a diverse user community, including both chemical biologists and computational scientists. Here, we describe the latest upgrade of this community-effort, SynergyFinder release 3.0, introducing a number of novel features that support interactive multi-sample analysis of combination synergy, a novel consensus synergy score that combines multiple synergy scoring models, and an improved outlier detection functionality that eliminates false positive results, along with many other post-analysis options such as weighting of synergy by drug concentrations and distinguishing between different modes of synergy (potency and efficacy). Based on user requests, several additional improvements were also implemented, including new data visualizations and export options for multi-drug combinations. With these improvements, SynergyFinder 3.0 supports robust identification of consistent combinatorial synergies for multi-drug combinatorial discovery and clinical translation.
format Online
Article
Text
id pubmed-9252834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92528342022-07-05 SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples Ianevski, Aleksandr Giri, Anil K Aittokallio, Tero Nucleic Acids Res Web Server Issue SynergyFinder (https://synergyfinder.fimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the development of its functionality and graphical interface has been driven by a diverse user community, including both chemical biologists and computational scientists. Here, we describe the latest upgrade of this community-effort, SynergyFinder release 3.0, introducing a number of novel features that support interactive multi-sample analysis of combination synergy, a novel consensus synergy score that combines multiple synergy scoring models, and an improved outlier detection functionality that eliminates false positive results, along with many other post-analysis options such as weighting of synergy by drug concentrations and distinguishing between different modes of synergy (potency and efficacy). Based on user requests, several additional improvements were also implemented, including new data visualizations and export options for multi-drug combinations. With these improvements, SynergyFinder 3.0 supports robust identification of consistent combinatorial synergies for multi-drug combinatorial discovery and clinical translation. Oxford University Press 2022-05-17 /pmc/articles/PMC9252834/ /pubmed/35580060 http://dx.doi.org/10.1093/nar/gkac382 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Web Server Issue
Ianevski, Aleksandr
Giri, Anil K
Aittokallio, Tero
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title_full SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title_fullStr SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title_full_unstemmed SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title_short SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
title_sort synergyfinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
topic Web Server Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252834/
https://www.ncbi.nlm.nih.gov/pubmed/35580060
http://dx.doi.org/10.1093/nar/gkac382
work_keys_str_mv AT ianevskialeksandr synergyfinder30aninteractiveanalysisandconsensusinterpretationofmultidrugsynergiesacrossmultiplesamples
AT girianilk synergyfinder30aninteractiveanalysisandconsensusinterpretationofmultidrugsynergiesacrossmultiplesamples
AT aittokalliotero synergyfinder30aninteractiveanalysisandconsensusinterpretationofmultidrugsynergiesacrossmultiplesamples